Evidence map›Paper›PMID 39867336›Full record

ArticleRSC advances2025

Tetrazolium iridium complexes as potential antibacterial agents.

Yifei Lu, Xiujuan Zhang, Minmin Song, Hua Xie, Shuhua Chen, Yuyang Zhou, Junli Jia, Huamin Tang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yifei LuDepartment of Immunology, School of Basic Medical Sciences, Nanjing Medical University Nanjing 211166 Jiangsu P. R. China jljia2016@njmu.edu.cn htang@njmu.edu.cn.
Xiujuan ZhangDepartment of Immunology, School of Basic Medical Sciences, Nanjing Medical University Nanjing 211166 Jiangsu P. R. China jljia2016@njmu.edu.cn htang@njmu.edu.cn.
Minmin SongDepartment of Immunology, School of Basic Medical Sciences, Nanjing Medical University Nanjing 211166 Jiangsu P. R. China jljia2016@njmu.edu.cn htang@njmu.edu.cn.
Hua XieJintan Hospital Affiliated to Jiangsu University P. R. China.
Shuhua ChenDepartment of Critical Care Medicine, Changzhou Cancer Hospital Changzhou 213001 P. R. China.
Yuyang ZhouSchool of Chemistry and Life Sciences, Suzhou University of Science and Technology Suzhou 215009 Jiangsu P. R. China zhouyuyang@mail.usts.edu.cn.ORCID https://orcid.org/0000-0002-8377-2641
Junli JiaDepartment of Immunology, School of Basic Medical Sciences, Nanjing Medical University Nanjing 211166 Jiangsu P. R. China jljia2016@njmu.edu.cn htang@njmu.edu.cn.
Huamin TangDepartment of Immunology, School of Basic Medical Sciences, Nanjing Medical University Nanjing 211166 Jiangsu P. R. China jljia2016@njmu.edu.cn htang@njmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this work, three iridium(iii) tetrazolato complexes have been used in antibacterial, biofilm removal and for other bioactivities for the first time. Notably, these iridium(iii) tetrazolato complexes with high antibacterial, especially, Ir-CF

Identifiers

PMID39867336
PMCPMC11756349

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.